Regenerative medicine: the emergence of an industry

Over the last quarter of a century there has been an emergence of a tissue engineering industry, one that has now evolved into the broader area of regenerative medicine. There have been ‘ups and downs’ in this industry; however, it now appears to be on a track that may be described as ‘back to the future’. The latest data indicate that for 2007 the private sector activity in the world for this industry is approaching $2.5 billion, with 167 companies/business units and more than 6000 employee full time equivalents. Although small compared with the medical device and also the pharmaceutical industries, these numbers are not insignificant. Thus, there is the indication that this industry, and the related technology, may still achieve its potential and address the needs of millions of patients worldwide, in particular those with needs that currently are unmet.

[1]  I. Yannas.  Studies on the biological activity of the dermal regeneration template , 1998, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[2]  H. Green,et al.  Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes , 1977, Nature.

[3]  Board on Neuroscience.  Stem cells and the future of regenerative medicine , 2002 .

[4]  S. Badylak,et al.  Naturally occurring extracellular matrix as a scaffold for musculoskeletal repair. , 1999, Clinical orthopaedics and related research.

[5]  Chris Mason,et al.  Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010. , 2010, Regenerative medicine.

[6]  H Green,et al.  Cultured cells for the treatment of disease. , 1991, Scientific American.

[7]  S. Badylak,et al.  Porcine small intestinal submucosa (SIS): a bioscaffold supporting in vitro primary human epidermal cell differentiation and synthesis of basement membrane proteins. , 2001, Burns : journal of the International Society for Burn Injuries.

[8]  Ana Jaklenec,et al.  Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. , 2008, Tissue engineering. Part A.

[9]  S. Bruder,et al.  Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. , 2001, Trends in molecular medicine.

[10]  G. Naughton,et al.  The Advanced Tissue Sciences story. , 1999, Scientific American.

[11]  R M Nerem,et al.  Tissue engineering: from biology to biological substitutes. , 1995, Tissue engineering.

[12]  Robert M Nerem,et al.  Tissue engineering: confronting the transplantation crisis. , 2003, Advances in experimental medicine and biology.

[13]  Michael J Lysaght,et al.  Tissue engineering: the end of the beginning. , 2004, Tissue engineering.

[14]  M J Lysaght,et al.  An economic survey of the emerging tissue engineering industry. , 1998, Tissue engineering.

[15]  I. Yannas,et al.  Design of an artificial skin. I. Basic design principles. , 1980, Journal of biomedical materials research.

[16]  M J Lysaght.  Product development in tissue engineering. , 1995, Tissue engineering.

[17]  S. Segawa,et al.  End of the beginning , 1990, Nature.

[18]  G. Naughton,et al.  A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. , 2008, Artificial organs.

[19]  N. Parenteau,et al.  Skin: the first tissue-engineered products. , 1999, Scientific American.

[20]  M. Sefton,et al.  Tissue engineering. , 1998, Journal of cutaneous medicine and surgery.

[21]  JOHN F. BURKE,et al.  Successful Use of a Physiologically Acceptable Artificial Skin in the Treatment of Extensive Burn Injury , 1981, Annals of surgery.

[22]  Carl Sandburg.  Good Morning, America , 1928 .

[23]  E Bell,et al.  The reconstitution of living skin. , 1983, The Journal of investigative dermatology.

[24]  Peter J. Donovan,et al.  Derivation of pluripotent stem cells from cultured human primordial germ cells , 1998 .

[25]  Shinya Yamanaka,et al.  A Fresh Look at iPS Cells , 2009, Cell.

[26]  C. Ohlsson,et al.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.

[27]  M J Lysaght,et al.  The growth of tissue engineering. , 2001, Tissue engineering.

[28]  Ejnar Eriksson,et al.  Treatment of deep cartilage knee defects , 1998, Knee Surgery, Sports Traumatology, Arthroscopy.

[29]  Alexis Carrel,et al.  The culture of organs , 1938 .

[30]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.